In this regard, the release of anti-inflammatory cytokines from skeletal muscle contraction, cortisol elevations, prostaglandin E2, and soluble receptors against tumor necrosis factor and interleukin 2, and increased mobilization of immunoregulatory leukocyte subtypes may be relevant in attenuating the cytokine release in COVID-19. This evidence concerns the gene IL2 and COVID-19.